TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
VCYT

Veracyte Inc

Healthcare · Diagnostics & Research

43.80$ +1.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,406 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCYT
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
10 19 80 65 75 101 79 121 275 457 1,188 1,156 1,115 1,300 1,406
8.6 16 76 43 48 74 54 97 188 376 243 249 286 372 488
7.6 14 71 35 39 59 34 78 159 349 173 154 216 239 363
7.6 14 71 35 39 59 34 78 159 349 177 179 216 289 413
0.2 0.6 1.1 3.1 3.5 8.8 13 13 19 18 41 44 40 47 45
0.3 1.1 2.6 3.7 3.8 3.5 5.3 3.4 6.8 4.7 11 14 16 22 21
1.7 2.4 3.0 4.2 10 11 9.7 8.9 8.9 9.0 31 31
0.0 1.1 1.1 1.1 1.1 1.1 2.7 2.7 708 696 703 746 767
0.2 0.3 16 15 14 13 12 65 60 203 175 89 102 89
1.9 14 23 23 24 41 41 41 36 36 91 81 71 124 96
1.9 9.0 15 17 15 12 12 13 17 17 64 63 61 79 60
4.9 5.0 26 25 1.4 1.4 1.6 4.8 4.1 5.1 7.5 4.1
0.6 1.9 5.3 7.4 5.1 2.4 3.9 2.5 2.3 3.1 12 12 13 8.6 4.6
4.9 4.9 5.0 26 25 24 0.7 0.8
8.5 4.9 56 41 51 60 37 80 239 421 1,097 1,075 1,044 1,176 1,310
-41 -60 56 -115 -149 -180 -211 -234 -247 -282 -357 -394 -468 -444 -378
14 14 4.2 22 26 29 34 37 46 53 68 72 73 78 81

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?